Clinical trial Recruiting at 1 site Interventional Ages 15 to 18

AVE-Neurofeedback for Academic Anxiety and Divergent Thinking

Official title: Efficacy of a Multisensory Audiovisual Entrainment Neurofeedback for Academic Anxiety Regulation and Divergent Thinking: A Randomized Controlled Trial Study

Run by Sma Negeri 1 Nganjuk · NCT07745335 · Data updated 2026-11-12

This study tests an adaptive brain‑computer interface that combines neurofeedback and audiovisual entrainment to help high school students reduce academic anxiety and boost creative thinking.

Quick facts

Study typeInterventional
Ages15 Years to 18 Years
SexAll
Enrollment240 (estimated)
SponsorSma Negeri 1 Nganjuk
Academic / other
Locations3 sites (Magelang, Central Java and 2 other locations)
StatusRecruiting
StartedSeptember 4, 2026
Main results expectedDecember 25, 2026
Study endsJanuary 1, 2027
Registry record updatedSeptember 2, 2026
Trial IDNCT07745335 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are senior high school students aged 15–18 with elevated academic anxiety, capable of understanding procedures, and able to provide consent (with parental consent as required).

Probably not a fit

Students with epilepsy, significant neurological or psychiatric disorders, current psychoactive medication affecting EEG, or recent neurofeedback training may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial tests an Audiovisual Entrainment Neurofeedback (AVE-NFB) system against neurofeedback alone, audiovisual entrainment alone, and a sham control in senior high school students with elevated academic anxiety. Participants are randomly assigned to one of four groups and assessed for changes in resting-state alpha power, anxiety, autonomic regulation, and divergent thinking, with short- and longer-term follow-ups. The study uses real-time EEG feedback integrated into an adaptive closed-loop design to deliver personalized reinforcement based on neural activity. Primary aim is to see whether AVE-NFB yields greater increases in alpha-band power compared with the other approaches. Secondary aims include reductions in academic anxiety, improvements in autonomic nervous system regulation, and enhancements in divergent thinking, evaluated at one week and one month post-intervention.

Why it matters

Potential benefit: If successful, students may experience reduced academic anxiety and improved creative thinking, potentially supporting better classroom performance.

How similar studies have gone: Neurofeedback and audiovisual entrainment have shown promise individually; this study extends them in an adaptive, closed-loop combination, which is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Senior high school students aged 15-18 years.
* Elevated academic anxiety according to screening assessment.
* Able to understand study procedures.
* Willing to provide written informed consent (and parental consent where required).

Exclusion Criteria:

* History of epilepsy or seizure disorders.
* Neurological disorders.
* Severe psychiatric disorders.
* Current psychoactive medication affecting EEG activity.
* Significant visual impairment incompatible with photic stimulation.
* Previous neurofeedback training within the last six months.

Where it's running

  • Rumah Sakit Daerah (RSD) Nganjuk
    Nganjuk, East Java, Indonesia
    Recruiting
  • SMA Taruna Nusantara
    Magelang, Central Java, Indonesia
    Not yet recruiting
  • SMA Negeri 1 Nganjuk
    Nganjuk, East Java, Indonesia
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.